BTMD · biote Corp
United States · RS rating 6 · As of 2026-10-14
| Price | 1.13 USD |
|---|---|
| 1-day change | +8.7% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 12 / 5 / 11 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 14 / 6 / 1 |
| Industry group (rank) | Medical-Ethical Drugs (91) |
| EPS growth Q/Q | -72.7% |
| Sales growth Q/Q | -3.2% |
| Distance from 52-week high | +64.6% |
| Market cap (USD) | $71.1M |